Of note, recent studies suggest that CD200-CD200 receptor (CD200R) interaction might be essential in controlling the myeloid heterogeneity in tumours by a mechanism involving CD200-expressing endothelial cells [107, 108]. This evidence concerns the gene CD200 and neoplasm.